Download Document

Adis R&D
Insight™
Vendor Update
SLA P&HT Division Meeting
April 8, 2008
Adis R&D Insight - Statistics
•
•
•
•
•
•
•
•
•
•
•
Total number of RDI drug profiles = 23,296
Number of new profiles added per month = 80
Number of significant updates per month = 992
Active drug profiles = 43.1% of the total database.
Inactive/discontinued drug profiles = 56.9% of database.
Number of profiles with chemical structures = 8952
Number of companies covered = 3589
Number of company profiles linked = 406
Number of companies tracked by Lehman Bros = 80-100
Number of profiles with a Lehman table = 995
Therapeutic Area Coverage = ALL plus Diagnostic agents,
Cell therapies, Gene therapies and Vaccines.
• Number of Indications = 1283
*February 2008
Adis R&D Insight: Sources
• Detailed drug profiles derived from the
following sources
– Company contacts
– Press releases
– International conferences
– Company websites
– More than 1,300 biomedical / medical
journals
Adis R&D Insight NEW! For 2007/2008
•
•
•
•
Upgraded search functionality
Improved ease of use
Links to original sources
Major improvements to customizing
preferences and push alerting
Upgraded Search Functionality
Biological and Chemical Class
 BROWSE function
 Separate lists for
Biological and Chemical
classes
 List View/Tree View
option
 Allows searching on
synonyms
Upgraded Search Functionality
Route and Formulation
 New tab allows search by
• Route of administration
• Formulation
Upgraded Search Functionality
Organization
 Renamed parameter for better classification of drug developers
 Search by Organization Type or Ownership Type
Upgraded Search Functionality
Phase
‘Highest Phase’ and ‘Phase is’
 New ‘Phase filter’ option
 Updated and expanded Phase list
Upgraded Search Functionality
Country Hierarchy
• Country searching is expanded to provide the ability to confidently
and simply search by broad geographical / political region.
• Addition of ‘Tree View’
Upgraded Search Functionality
Fast Track
• Allows to search compounds that were assigned Fast Track status by the FDA
in the US
Upgraded Search Functionality
‘Orphan Drug’
 Orphan Drug designation for a particular indication
 Orphan designation country
‘Any Indication or Country’: search ALL profiles were Orphan Drug exists
Upgraded Search Functionality
Full Text
 ‘Full Text’ has replaced the ‘Text Contains’ free text searching option.
 Can be partnered with a Category, which will search a specific part of
the profile.
 Search term will be highlighted in yellow when you open the profile
Improved Ease of Use
Addition of Disease Qualifiers
a qualifier may be added to an indication
a qualifier comment can be added to provide additional information
Improved Ease of Use
More Tabular Content
 Route listed in Phase of Development Table
Orphan Designation
 Brand Name Table
Links to Original Sources
Journal FullText option in records
 Open access linking capability to link to
your journal holdings
Customization
Results Page
 Choose Columns for viewing on Results Page
Customization
Development table
 Filtering by search
 Sorting by heading
Alerts
New ALERTS features:
 Multiple email addresses can be set up for a single email alert
 Searches from both R&D Insight and Clinical Trials Insight can be included in a
single alert
 Users will be able to export, print, chart results from their Alerts
 Run search from last alert
Customer Engagement Activities- 2007
• Online Surveys conducted
• Key Takeaways
– Areas of expanding importance are drug
targets and new formulations
– Greater need for financial data, patent, and
licensing/deals opportunities
– Improved ability in accessing specific data
points
– Timeliness and comprehensiveness is critical
Next Steps for Adis R&D Insight
• Customer roundtables to determine and
continue to drive specific major
enhancements
– US and Europe during the weeks of
March 31st and April 4th
– Representation from all user and
customer types
• Improve comprehensiveness of coverage
through the content acquisition initiative
(technology and process review)
Feedback and Comments
Adis Business Intelligence
Client Services
[email protected]
1-877-872-2347 option 1